The legislation would allow drugmakers to share economic information with payers beyond what is included on the FDA-approved label.
The draft would allow drugmakers to share off-label economic data with payers, a practice that until now has been considered taboo, and require the FDA to assess patient experience data in regulatory decisions, in addition to boosting funding for the NIH.
Shire's ADHD treatment Vyvanse won a label expansion into treating moderate-to-severe binge-eating disorder (BED) Friday. One analyst says that disease awareness and detailing efforts are crucial to the drug's commercial plans in the category.
The artwork is meant to inspire debate and donations for vaccinations.
"We are living in an era of great medical technological innovations. However, this is shifting healthcare back home and expecting patients to understand excessive medical information and follow complex instructions."
CMS redefined the Sunshine CME exemption, still allowing most payments to go unreported.
The new initiative will look to recruit a teenager with epilepsy to appear in the next iteration of its educational comic book series.
Using the same methods they use to stimulate demand for a brand, agencies can educate communities and ultimately transform how countries approach healthcare, urges H.E. Toyin Saraki.
Recent research suggests nurse practitioners and physicians assistants have a growing appetite for digital patient resources from industry.
After a wave of feedback, the accreditor has deferred a ban on use of corporate logos in disclosures of commercial support.